• Products
  • Insights
  • Practice Management
  • Resources
  • About Us

Domestic Equity fund

Hartford Healthcare HLS Fund   


Actions

Domestic Equity fund

Hartford Healthcare HLS Fund   
Share Class - HLS IB (HBGHX)

Effective 12/31/17, this Fund is closed to certain qualified pension and retirement plans.  For more information, please refer to the fund's statutory prospectus.

Objective

Seeks long-term capital appreciation.

Overview

A stock fund that invests exclusively in health care, a sector that is experiencing innovations and breakthroughs across multiple subsectors.

Portfolio Management
Senior Managing Director
Global Industry Analyst
5
YRS
MANAGING THIS FUND
19
YRS
AT WELLINGTON MANAGEMENT
21
YRS
EXPERIENCE IN THIS INDUSTRY

The portfolio manager is supported by the full resources of Wellington.

Performance

PERFORMANCE %
 
CUMULATIVE %
(as of 6/30/2026)
AVERAGE ANNUAL TOTAL RETURNS %
(as of 6/30/2026)
YTD 1YR 3YR 5YR 10YR SI
Hartford Healthcare HLS IB 5.41 28.50 7.62 2.69 8.89 10.82
Benchmark 4.28 20.61 7.93 6.05 10.20 ---
Morningstar Health Category 9.54 36.60 10.61 3.11 9.69 ---
 
CUMULATIVE %
(as of 6/30/2026)
AVERAGE ANNUAL TOTAL RETURNS %
(as of 6/30/2026)
YTD 1YR 3YR 5YR 10YR SI
Hartford Healthcare HLS IB 5.41 28.50 7.62 2.69 8.89 10.82
Benchmark 4.28 20.61 7.93 6.05 10.20 ---
Morningstar Health Category 9.54 36.60 10.61 3.11 9.69 ---

Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted. For more current performance information to the most recent month ended, please visit hartfordfunds.com.

SI = Since Inception. Fund Inception: 05/01/2000

Characteristics

FUND ESSENTIALS (as of 5/31/2026)
Inception Date 05/01/2000
Net Assets $105 million
Total Operating Expenses 1.19%
Morningstar Category Health
Lipper Classification Health/Biotechnology Funds
CUSIP 416528693
Fund Number 2056
FUND STATS (as of 5/31/2026)
# of Holdings
80
% in Equities
99
% in Foreign Equities
8
Beta (3 year)
1.01
R Squared (3 year)
0.93
Standard Deviation
14.86%
Turnover
50%
Active Share
41%
Holdings Characteristics (as of 5/31/2026)
FUND S&P Composite 1500 Health Care Index
Price/Earnings
21.2x 15.4x
Price/Book
4.8x 4.8x
EPS Growth Rate
8.0% 8.2%
Asset Weighted Market Cap (billions)
$258.6 $316.6
Return on Equity
17.4% 31.2%
Median Market Cap (billions)
$12.6 $7.2
Top Ten Holdings (%) (as of 5/31/2026)
Eli Lilly & Co. 12.71
Merck & Co., Inc. 6.72
Johnson & Johnson 5.62
UnitedHealth Group, Inc. 4.91
Intuitive Surgical, Inc. 3.40
Elevance Health, Inc. 3.21
AbbVie, Inc. 3.16
Abbott Laboratories 2.78
Danaher Corp. 2.71
CVS Health Corp. 2.63
Total Portfolio % 47.85
Market Cap Distribution (%) (as of 5/31/2026)

Market Cap Header3

Less than $2 billion 2
$2 billion - $5 billion 6
$5 billion - $10 billion 5
Greater than $10 billion 87
Not Classified 0
Subsector Exposure (%)
Biopharma Large Cap 42
Medical Technology 24
Health Care Services 20
Biopharma Mid Cap 13
Biopharma Small Cap 2
Biopharma Large Cap 42
Medical Technology 25
Health Care Services 16
Biopharma Mid Cap 13
Biopharma Small Cap 3
Based on sub-adviser's classification of health care subsectors, which includes combining biotechnology and pharmaceuticals in terms of capitalization: biopharma small-cap, biopharma mid-cap, and biopharma large-cap. Excludes cash. May not total to 100% due to rounding.
distributions and capital gains
Distribution Date Distribution NAV ordinary income short term capital gains long term capital gains total distribution
8/25/2025 12.77 $0.0789 $0.3182 $0.4959 $0.8930
Past distributions are not indicative of future distributions.

Resources

Important Risks: Investing involves risk, including the possible loss of principal. Security prices fluctuate in value depending on general market and economic conditions and the prospects of individual companies. • Risks of focusing investments on the healthcare related sector include regulatory and legal developments, changes in funding or subsidies, patent and intellectual property considerations, intense competitive pressures, rapid technological changes, long and costly process for obtaining product approval by government agencies, potential product obsolescence, rising cost of medical products and services, and price volatility risk. • Small- and mid-cap securities can have greater risks and volatility than large-cap securities. • The securities of large market capitalization companies may underperform other segments of the market. • Foreign investments may be more volatile and less liquid than U.S. investments and are subject to the risk of currency fluctuations and adverse political, economic and regulatory developments.

Hartford HLS Funds are distributed by Hartford Funds Distributors, LLC (HFD), Member FINRA. Advisory services are provided by Hartford Funds Management Company, LLC (HFMC). The Funds are sub-advised by Wellington Management Company LLP. HFMC and Wellington Management are SEC registered investment advisers. Hartford Funds refers to HFD and HFMC, which are not affiliated with any sub-adviser.

4517827

The material on this site is for informational and educational purposes only. The material should not be considered tax or legal advice and is not to be relied on as a forecast. The material is also not a recommendation or advice regarding any particular security, strategy or product. Hartford Funds does not represent that any products or strategies discussed are appropriate for any particular investor so investors should seek their own professional advice before investing. Hartford Funds does not serve as a fiduciary. Content is current as of the publication date or date indicated, and may be superseded by subsequent market and economic conditions.

Investing involves risk, including the possible loss of principal. Investors should carefully consider a fund's investment objectives, risks, charges and expenses. This and other important information is contained in the mutual fund, or ETF summary prospectus and/or prospectus, which can be obtained from a financial professional and should be read carefully before investing.

Mutual funds are distributed by Hartford Funds Distributors, LLC (HFD), Member FINRA|SIPC. ETFs are distributed by ALPS Distributors, Inc. (ALPS). Advisory services may be provided by Hartford Funds Management Company, LLC (HFMC) or its wholly owned subsidiary, Lattice Strategies LLC (Lattice). Certain funds are sub-advised by Wellington Management Company LLP and/or Schroder Investment Management North America Inc (SIMNA). Schroder Investment Management North America Ltd. (SIMNA Ltd) serves as a secondary sub-adviser to certain funds. HFMC, Lattice, Wellington Management, SIMNA, and SIMNA Ltd. are all SEC registered investment advisers. The funds and other products referred to on this Site may be offered and sold only to persons in the United States and its territories.

Hartford Funds refers to HFD, Lattice, and HFMC, which are currently not affiliated with any sub-adviser or ALPS.

On June 3, 2026, The Hartford Insurance Group, Inc. (“The Hartford”) and Wellington announced that they had reached a definitive agreement under which Wellington Investment Advisors Holdings, LLP, Wellington’s corporate parent, will acquire Hartford Funds. Upon closing Hartford Funds will be integrated into Wellington’s U.S. Wealth business. The deal is expected to close in the first quarter of 2027, subject to regulatory and fund approvals. Upon closing, Hartford Funds would become an affiliate of Wellington. For more information, click here.

© Copyright 2026 Hartford Funds Management Group, Inc. All Rights Reserved. Not FDIC Insured | No Bank Guarantee | May Lose Value